Member Login
  1. Stocks
    2. /
  2. Bellus Health (TSX: BLU)
    3. /

TSX:BLU (Bellus Health)

About BLU

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bellus Health (TSX: BLU) Latest News

    Investing

    Why BELLUS Health (TSX:BLU) Stock Jumped 30% on the TSX Today!

    | Amy Legate-Wolfe

    BELLUS (TSX:BLU)(NASDAQ:BLU) stock went stratospheric with the promise of a new drug that could boost fourth-quarter revenue.

    Read more »

    Energy Stocks

    3 Bargain TSX Stocks to Buy While They’re Low

    | Christopher Liew, CFA

    Bargain deals are plenty, even if the TSX’s rally continues in July 2021. Buy shares of Canacol Energy stock, Fire…

    Read more »

    Cannabis Stocks

    3 Top Growth Stocks to Own Before They Take Off

    | Christopher Liew, CFA

    Growth investors should be eyeing the WELL Health Technologies stock, Fire & Flower stock, and BELLUS Health stock. If you…

    Read more »

    Dividend Stocks

    Got $2,000? 4 Top Stocks to Buy This Month

    | Christopher Liew, CFA

    Canadians with only $2,000 in capital can create a diversified portfolio that could deliver substantial gains. The top but affordable…

    Read more »

    Investing

    TFSA Investors: This Pharma Stock Could Rise Significantly

    | Nikhil Kumar

    Bellus Health Inc. (TSX:BLU)(NASDAQ:BLU) is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough.

    Read more »

    Cannabis Stocks

    2 TSX Stocks That Could Return 100% in 2021

    | Christopher Liew, CFA

    Two Canadian firms will benefit from the rapidly evolving health and wellness industry. The Bellus Health stock and Neptune Wellness…

    Read more »

    Investing

    Warren Buffett Is Betting Big on Drug Stocks

    | Christopher Liew, CFA

    Warren Buffett’s new positions in Q3 2020 are in four established pharma stocks. Bellus Health stock hasn’t taken off yet…

    Read more »

    Investing

    2 Top Oversold Stocks in the Coronavirus Market Crash

    | Christopher Liew, CFA

    Investors can watch out for the rebound of oversold assets like the Bellus Health stock and Chorus Aviation stock. The…

    Read more »

    Metals and Mining Stocks

    Canada Revenue Agency: 1 Major TFSA Mistake Could Cost You Thousands

    | Christopher Liew, CFA

    The Alacer Gold and Bellus Health stocks are showing strong earnings potential.

    Read more »

    Investing

    This Little-Known Stock Increased Over 100% in 2019!

    | Christopher Liew, CFA

    With a novel drug to treat two severe cough conditions under development, the potential gains from the Bellus Health stock…

    Read more »

    Investing

    This Biotech Stock Is Set to Climb 500%

    | Christopher Liew, CFA

    Bellus Health Inc. (TSX:BLU) could be the rising star of the biotech sector and the general market come 2020. Its…

    Read more »

    Investing

    Trudeau’s Drug Price Overhaul Threatens This Company

    | Christopher Liew, CFA

    BELLUS Health Inc. (TSX:BLU) is the latest revelation on the TSX. The healthcare stock is soaring this year. We hope…

    Read more »